JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

Alignment Healthcare, Inc.

Alignment Healthcare, Inc.

ALHC

0.00

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ: ALHC) with a Overweight and lowers the price target from $26 to $22.